Notably, PVT1, MYC, CCD26, and GSDMC were more amplified at 8q24.21, while VANGL, TRIM45, TTF2, and VTCN1 were more deleted at 12P13.1 in high AITS BC patients. This evidence concerns the gene MYC and breast cancer.